検索結果一覧

シンポジウム / Symposium

【E】シンポジウム1 (Symposium 1 (JSH-ASH Joint Symposium)) : Understanding molecular pathogenesis and biological behavior of MM to further improve its clinical outcome
 
日程
2013年10月11日(金)
時間
09:00 - 11:30
会場
第1会場 / Room No.1 (さっぽろ芸文館 1F ニトリ文化ホール)
座長・司会
照井 康仁 (Yasuhito Terui):1、Nikhil C. Munshi:2
1:The Cancer Institute Hospital Of JFCR, Japan、2:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston VA Healthcare System, Harvard Medical School Boston MA, USA

前へ戻る


Biology and molecular targets in multiple myeloma

演題番号 : SY1-1

Nikhil C. Munshi:1

1:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston VA Healthcare System, Harvard Medical School Boston MA, USA

Biology and molecular targets in multiple myeloma

Genome based therapeutics in myeloma

演題番号 : SY1-2

Alexander Keith Stewart:1

1:Division of Hematology - Oncology, Mayo Clinic Arizona, USA

Genome based therapeutics in myeloma

Future therapy for multiple myeloma through therapeutic targeting of cell signaling pathways

演題番号 : SY1-3

黒田 純也 (Junya Kuroda):1

1:Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Japan

Future therapy for multiple myeloma through therapeutic targeting of cell signaling pathways

Determinants of sensitivity to proteasome inhibitors and strategies to overcome acquired resistance against bortezomib in multiple myeloma

演題番号 : SY1-4

飯田 真介 (Shinsuke Iida):1、李 政樹 (Masaki Ri):1

1:Department of Medical Oncology & Immunology, Nagoya City University Graduate School of Medical Sciences, Japan

Determinants of sensitivity to proteasome inhibitors and strategies to overcome acquired resistance against bortezomib in multiple myeloma